0.3300
+0.0010
+(0.30%)
At close: April 17 at 4:00:01 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BORTHWICK KATHLEEN Chief Financial Officer | Sale | Feb 11, 2025 | 41,283 |
| CALE EDGAR B. General Counsel | Sale | Jan 2, 2024 | 45,995 |
| FORMAN MARK S M.D., PH.D. Officer | Sale | Feb 13, 2024 | 48,631 |
| FOTOPOULOS ALEXANDROS Chief Technology Officer | Sale | Jun 16, 2023 | 28,693 |
| KING SIMONA Chief Financial Officer | Sale | Jul 28, 2023 | 23,994 |
| LYNX1 CAPITAL MANAGEMENT LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 27, 2024 | -- |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 14, 2025 | -- |
Related Tickers
ORIC ORIC Pharmaceuticals, Inc.
4.7700
+1.71%
PRLD Prelude Therapeutics Incorporated
0.8100
+5.19%
ANTX AN2 Therapeutics, Inc.
1.2600
-1.56%
HOOK HOOKIPA Pharma Inc.
0.7733
0.00%
ACXP Acurx Pharmaceuticals, Inc.
0.3728
-3.19%
ADCT ADC Therapeutics SA
1.2100
+4.31%
KYMR Kymera Therapeutics, Inc.
25.97
+3.80%
GBIO Generation Bio Co.
0.3921
+13.03%
QTTB Q32 Bio Inc.
2.1200
+14.59%
RLYB Rallybio Corporation
0.2500
-0.71%